Zobrazeno 1 - 10
of 2 581
pro vyhledávání: '"ANTI-IGE"'
Autor:
A. S. Prilutskiy, O. A. Prilutskaia
Publikováno v:
Аллергология и Иммунология в Педиатрии, Vol 0, Iss 2, Pp 38-49 (2024)
Allergen-specific immunotherapy is a method of treatment and prevention of respiratory allergic diseases. Carrying it out changes and improves the course of allergic diseases. One of the promising and new approaches is the combination of allergen-spe
Externí odkaz:
https://doaj.org/article/37c05af7d0d24d2e8b65eea45bd9d499
Publikováno v:
In The Journal of Allergy and Clinical Immunology January 2025 155(1):24-30
Publikováno v:
In The Journal of Allergy and Clinical Immunology January 2025 155(1):12-23
Autor:
Dantzer, Jennifer A. ∗, Wood, Robert A.
Publikováno v:
In The Journal of Allergy and Clinical Immunology January 2025 155(1):1-11
Publikováno v:
Egyptian Journal of Chest Disease and Tuberculosis, Vol 73, Iss 1, Pp 7-12 (2024)
Background anti-IgE (Omalizumab) is one of the targeted therapies for severe bronchial asthma. Its real-life safety is still under scrutiny.The aim of the study was to evaluate the persistent efficacy and safety of Omalizumab as a long-term treatment
Externí odkaz:
https://doaj.org/article/56231228d7cc436586e8bd7a419dab90
Publikováno v:
BMC Pulmonary Medicine, Vol 23, Iss 1, Pp 1-8 (2023)
Abstract Background Omalizumab is a valuable alternative treatment for allergic bronchopulmonary aspergillosis (ABPA). The effectiveness and safety of this medication have not been confirmed. The main purpose of this study was to evaluate the effecti
Externí odkaz:
https://doaj.org/article/51fbb47cf2d540338b1657f1df6b545a
Autor:
P.C. Kathuria, Manisha Rai
Publikováno v:
Indian Journal of Allergy Asthma and Immunology, Vol 38, Iss 1, Pp 1-2 (2024)
Asthma is a complex heterogeneous inflammatory airway disorder. Inflammation is usually accompanied by an increase in airway smooth muscle mass, thickening of subepithelial lamina reticularis, matrix deposition in the airway walls, an increase in mic
Externí odkaz:
https://doaj.org/article/a1b9f6f1d9af4298867ff0cb5b227600
Autor:
Sarah Kidwai, Pietro Barbiero, Irma Meijerman, Alberto Tonda, Paula Perez‐Pardo, Pietro Lio ́, Anke H. van derMaitland‐Zee, Daniel L. Oberski, Aletta D. Kraneveld, Alejandro Lopez‐Rincon
Publikováno v:
Clinical and Translational Allergy, Vol 13, Iss 11, Pp n/a-n/a (2023)
Abstract Background Not being well controlled by therapy with inhaled corticosteroids and long‐acting β2 agonist bronchodilators is a major concern for severe‐asthma patients. The current treatment option for these patients is the use of biologi
Externí odkaz:
https://doaj.org/article/dc82ea5a34754f9ab2041cdf4636cd31
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.